Suppr超能文献

用于治疗肺动脉高压的天然产物:作用机制、研究进展及未来机遇

Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities.

作者信息

Zeng Zuomei, Wang Xinyue, Cui Lidan, Wang Hongjuan, Guo Jian, Chen Yucai

机构信息

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100029, China.

出版信息

Curr Issues Mol Biol. 2023 Mar 13;45(3):2351-2371. doi: 10.3390/cimb45030152.

Abstract

Pulmonary hypertension (PH) is a lethal disease due to the remodeling of pulmonary vessels. Its pathophysiological characteristics include increased pulmonary arterial pressure and pulmonary vascular resistance, leading to right heart failure and death. The pathological mechanism of PH is complex and includes inflammation, oxidative stress, vasoconstriction/diastolic imbalance, genetic factors, and ion channel abnormalities. Currently, many clinical drugs for the treatment of PH mainly play their role by relaxing pulmonary arteries, and the treatment effect is limited. Recent studies have shown that various natural products have unique therapeutic advantages for PH with complex pathological mechanisms owing to their multitarget characteristics and low toxicity. This review summarizes the main natural products and their pharmacological mechanisms in PH treatment to provide a useful reference for future research and development of new anti-PH drugs and their mechanisms.

摘要

肺动脉高压(PH)是一种因肺血管重塑而导致的致命疾病。其病理生理特征包括肺动脉压升高和肺血管阻力增加,进而导致右心衰竭和死亡。PH的病理机制复杂,包括炎症、氧化应激、血管收缩/舒张失衡、遗传因素和离子通道异常。目前,许多治疗PH的临床药物主要通过舒张肺动脉发挥作用,治疗效果有限。最近的研究表明,各种天然产物因其多靶点特性和低毒性,对于具有复杂病理机制的PH具有独特的治疗优势。本文综述了治疗PH的主要天然产物及其药理机制,为未来新型抗PH药物及其作用机制的研发提供有益参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed6b/10047369/7f75d7cb9361/cimb-45-00152-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验